Overview

Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy

Status:
Unknown status
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The Investigators objective is to compare the clinical efficacy of a single-day protocol with a short-course protocol for PCNL. The investigator hope is to reduce the use of possibly unnecessary prolonged antibiotic use, reduce hospital costs and prevent the further propagation of resistant microbes.
Phase:
Phase 3
Details
Lead Sponsor:
Northwell Health
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Cephalosporins
Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Fluoroquinolones
Metronidazole
Sulbactam